About 700 women from Bondo, Nyanza in Kenya were in the process of of a HIV prevention study which has not been concluded but will be put to a stop. This is because the trial is not yielding positive results . The study was funded by USAID and was called ‘FEM-PrEP’. The aim was to find out whether ‘Truvada’ could be taken daily by HIV negative women in order to prevent HIV infections.
The results are a bit disappointing to the scientists involved because a different study proved that Truvada could prevent HIV infections among homosexuals. The FEM- PrEP study is also being conducted in South Africa and Tanzania. The study will be gradually phased out over a period of 5 months to enable the participants pay their final visits to the hospital.